Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank80
Studio
Year-over-Year Change

Free cash flow yield

Latest
-5.80%
↑ 68% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-18.19%
Historical baseline
PeriodValueYoY Change
2025-5.80%+79.2%
2024-27.85%-6.8%
2023-26.08%+15.0%
2022-30.67%-93.6%
2021-15.84%-449.1%
2020-2.88%-